Nicolas J. Mueller
Expertise in
3
conditions

Nicolas J. Mueller

Infectious Disease
Zurich, ZH, CH 
Expertise in
3
conditions
Zurich, ZH, CH 

Overview

Nicolas Mueller is an Infectious Disease expert in Zurich, Switzerland. Mr. Mueller is highly rated in 3 conditions, according to our data. His top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Pneumocystis Jiroveci Pneumonia, and Nocardiosis.

His clinical research consists of co-authoring 198 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Infectious Disease

Gender

Male

Locations

Zurich, ZH, Switzerland
Other Locations
Dubendorf, ZH 8600, Switzerland
Basel, BS, Switzerland
Wadenswil, ZH 8820, Switzerland
Fribourg, FR 1700, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomised Controlled Trials to Assess Approved SARS-CoV-2 Vaccines in Immunocompromised Patients: A Master Protocol for the Set-up of a Swiss Cohorts Based Trial Platform
Randomised Controlled Trials to Assess Approved SARS-CoV-2 Vaccines in Immunocompromised Patients: A Master Protocol for the Set-up of a Swiss Cohorts Based Trial Platform
Enrollment Status: Completed
Publish Date: January 25, 2024
Intervention Type: Biological
Study Drugs: Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19 Vaccine
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug, Other
Study Phase: Phase 3
Monitoring of Specific Cytomegalovirus Cell-mediated Immunity (CMV-CMI) for Optimization of Preventive Strategies Against CMV Infection in High-risk Solid-organ Transplant Recipients
Monitoring of Specific Cytomegalovirus Cell-mediated Immunity (CMV-CMI) for Optimization of Preventive Strategies Against CMV Infection in High-risk Solid-organ Transplant Recipients
Enrollment Status: Completed
Publish Date: April 28, 2021
Intervention Type: Other
Study Phase: Not Applicable
Reducing the Burden of Influenza After Solid-Organ Transplantation: the STOP-FLU Trial [Swiss Trial in Solid Organ Transplantation on Prevention of Influenza]
Reducing the Burden of Influenza After Solid-Organ Transplantation: the STOP-FLU Trial [Swiss Trial in Solid Organ Transplantation on Prevention of Influenza]
Enrollment Status: Completed
Publish Date: December 17, 2020
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
View 3 Less Clinical Trials

198 Total Publications

Xenotransplantation: from proof of concept to clinical reality.
Xenotransplantation: from proof of concept to clinical reality.
Journal: Swiss medical weekly
Published: October 14, 2025
Similar Experts
Philip Bruggmann
Expertise in
2
conditions
Philip Bruggmann
Infectious Disease
Expertise in
2
conditions
Philip Bruggmann
Infectious Disease
Zurich, ZH, CH 
 (0.1 miles away)

Philip Bruggmann is an Infectious Disease expert in Zurich, Switzerland. Mr. Bruggmann is highly rated in 2 conditions, according to our data. His top areas of expertise are Hepatitis C, Hepatitis, Hepatitis B, and Severe Acute Respiratory Syndrome (SARS).

Frequently Asked Questions about Nicolas J. Mueller

Is Nicolas J. Mueller a top-rated expert for Cytomegalovirus Infection?

MediFind is an objective health platform that identifies experts based on real-world data. Nicolas J. Mueller is classified as an Advanced expert for Cytomegalovirus Infection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Nicolas J. Mueller specialize in?

While Nicolas J. Mueller is a Infectious Disease, they have specific expertise in Cytomegalovirus Infection, Cytomegalic Inclusion Disease, and Pneumocystis Jiroveci Pneumonia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Nicolas J. Mueller participate in research or clinical trials?

Yes. Nicolas J. Mueller has published 198 articles and abstracts on conditions like Cytomegalovirus Infection. You can view a list of Nicolas J. Mueller's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mueller's expertise for a condition
ConditionClose
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile